DE60134854D1 - Orale zubereitungen, die wirtsantwortmodulierenden wirkstoffe enthalten - Google Patents

Orale zubereitungen, die wirtsantwortmodulierenden wirkstoffe enthalten

Info

Publication number
DE60134854D1
DE60134854D1 DE60134854T DE60134854T DE60134854D1 DE 60134854 D1 DE60134854 D1 DE 60134854D1 DE 60134854 T DE60134854 T DE 60134854T DE 60134854 T DE60134854 T DE 60134854T DE 60134854 D1 DE60134854 D1 DE 60134854D1
Authority
DE
Germany
Prior art keywords
agents
oral
present
host
oral cavity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60134854T
Other languages
English (en)
Inventor
Matthew Joseph Doyle
Stephen Joseph Hunter-Rinderle
Robert Ernest Singer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24432968&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60134854(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Application granted granted Critical
Publication of DE60134854D1 publication Critical patent/DE60134854D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
DE60134854T 2000-06-30 2001-06-28 Orale zubereitungen, die wirtsantwortmodulierenden wirkstoffe enthalten Expired - Lifetime DE60134854D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60760200A 2000-06-30 2000-06-30
PCT/US2001/020515 WO2002002096A2 (en) 2000-06-30 2001-06-28 Oral compositions comprising host-response modulating agent

Publications (1)

Publication Number Publication Date
DE60134854D1 true DE60134854D1 (de) 2008-08-28

Family

ID=24432968

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60134854T Expired - Lifetime DE60134854D1 (de) 2000-06-30 2001-06-28 Orale zubereitungen, die wirtsantwortmodulierenden wirkstoffe enthalten

Country Status (12)

Country Link
US (1) US8277782B2 (de)
EP (1) EP1294367B1 (de)
JP (1) JP4754155B2 (de)
CN (1) CN1536989A (de)
AT (1) ATE401065T1 (de)
AU (1) AU2001271544A1 (de)
CA (1) CA2415065C (de)
DE (1) DE60134854D1 (de)
ES (1) ES2309076T3 (de)
MX (1) MXPA03000043A (de)
PE (1) PE20020102A1 (de)
WO (1) WO2002002096A2 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8283135B2 (en) * 2000-06-30 2012-10-09 The Procter & Gamble Company Oral care compositions containing combinations of anti-bacterial and host-response modulating agents
US20040101494A1 (en) 2002-11-26 2004-05-27 Scott Douglas Craig Chewable solid unit dosage forms and methods for delivery of active agents into occlusal surfaces of teeth
WO2005025527A1 (de) 2003-09-09 2005-03-24 Dsm Ip Assets B.V. Oral wirkendes im wesentlichen wasserfreies topisches mittel enthaltend ein oder mehrere oxidationsempfindliche stoffe
AU2004289248B2 (en) * 2003-11-07 2012-05-03 U.S. Smokeless Tobacco Company Llc Tobacco compositions
US8627828B2 (en) 2003-11-07 2014-01-14 U.S. Smokeless Tobacco Company Llc Tobacco compositions
PL1748767T3 (pl) 2004-05-28 2012-08-31 Unigen Inc 1-(3-metylo-2,4-dimetoksyfenylo)-3-(2',4'-dihydroksyfenylo)-propan jako silny inhibitor tyrozynazy
US8168161B2 (en) * 2004-12-22 2012-05-01 Hill's Pet Nutrition, Inc. Method to promote oral health in companion animals
JP2006182662A (ja) * 2004-12-27 2006-07-13 Lion Corp 歯磨剤組成物
US20080045575A1 (en) * 2004-12-29 2008-02-21 Van Dyke Thomas E Delivery of H2 Antagonists
US20070105063A1 (en) 2005-11-04 2007-05-10 Pinyayev Aleksey M Multi-function oral care device
US20070140990A1 (en) * 2005-12-21 2007-06-21 Nataly Fetissova Oral Compositions Comprising Propolis
KR101531185B1 (ko) 2006-07-20 2015-06-25 이준 파마슈티컬스 코포레이션 필름 전달 린스
US8858995B2 (en) 2008-03-10 2014-10-14 University Of Louisville Research Foundation, Inc. Methods and compositions for controlled delivery of phytochemical agents
AU2009223653B2 (en) * 2008-03-10 2014-07-31 University Of Louisville Research Foundation, Inc. Methods and compositions for controlled delivery of phytochemical agents
PL3542780T3 (pl) 2008-07-21 2022-05-02 Unigen, Inc. Szereg związków wybielających (rozjaśniających)
WO2011106089A1 (en) * 2010-02-24 2011-09-01 Bisco, Inc. Benzalkonium chloride compositions for inhibiting the hydrolytic activity of endogenous matrix metalloproteinases in dental restorations
EP2688860B1 (de) 2011-03-24 2020-12-09 Unigen, Inc. Verbindungen und verfahren zur herstellung von diarylpropanen
US8731747B2 (en) 2011-04-28 2014-05-20 General Electric Company Communication systems and method for a rail vehicle or other powered system
US8798807B2 (en) 2011-06-13 2014-08-05 General Electric Company Data distribution system and method for distributing data in a vehicle
US8510026B2 (en) 2011-06-13 2013-08-13 General Electric Company Data conversion system and method for converting data that is distributed in a vehicle
US8620552B2 (en) 2011-06-13 2013-12-31 General Electric Company Data communication system and method for communicating data in a vehicle
AU2012315782B2 (en) 2011-09-30 2015-10-29 Perio Sciences, Llc Antioxidant compositions for treatment of inflammation or oxidative damage
US20130274650A1 (en) * 2012-04-17 2013-10-17 Luitpold Pharmaceuticals, Inc. Stabilized ketorolac compositions
US20150210964A1 (en) 2014-01-24 2015-07-30 The Procter & Gamble Company Consumer Product Compositions
CN110024726B (zh) * 2019-04-03 2022-03-08 中国水产科学研究院长江水产研究所 天然产物在激活斑点叉尾鮰核受体ahr1和ahr2活性中的应用
US20210177710A1 (en) * 2019-04-10 2021-06-17 Black Tulip Management, Inc. Oral rinse compositions for reducing pathogens underlying and for treating periodontal disease and oral malodor in the canine
CA3136620C (en) * 2019-04-10 2023-12-05 Black Tulip Management, Inc. Oral rinse compositions for reducing pathogens underlying tooth decay, periodontitis and oral malodor
CN112494483B (zh) * 2020-11-13 2022-09-02 兰州大学 一种二硫杂环戊烯硫酮类化合物在抗菌方面的用途
CN115024355B (zh) * 2022-06-09 2023-06-09 宁波大学科学技术学院 对冷鲜肉保鲜的基于大蒜素的复合载体涂层的制备方法

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4599228A (en) * 1981-01-19 1986-07-08 Vipont Laboratories, Inc. Antimicrobial agent
US5531982A (en) * 1987-01-30 1996-07-02 Colgate Palmolive Company Antimicrobial oral composition
US5204089A (en) * 1989-08-30 1993-04-20 Mitsui Norin Co., Ltd. Method of preventing the formation or aggrevation of dental plaque and method for reducing cariogenesis
US5198220A (en) 1989-11-17 1993-03-30 The Procter & Gamble Company Sustained release compositions for treating periodontal disease
US5464609A (en) * 1990-03-16 1995-11-07 The Procter & Gamble Company Use of ketorolac for treatment of oral diseases and conditions
ES2077703T3 (es) * 1990-03-30 1995-12-01 Suntory Ltd Inhibidores de la glucosiltransferasa, asi como metodos para la prevencion de la caries dental y alimentos anticaries que utilizan estos inhibidores.
JPH0489428A (ja) 1990-07-30 1992-03-23 Kao Corp 多形核白血球活性化剤
US5147632A (en) * 1990-10-31 1992-09-15 Warner-Lambert Company Anti-plaque compositions comprising a combination of morpholinoamino alcohol and chelating agent
US5356615A (en) * 1991-01-30 1994-10-18 Colgate Palmolive Company Antiplaque oral compositions
GB9110721D0 (en) * 1991-05-17 1991-07-10 Unilever Plc Dentifrice compositions
US5656591A (en) * 1992-01-23 1997-08-12 Morinaga Milk Industry Co., Ltd. Antimicrobial agents and method for treating products therewith
CN1075868A (zh) 1992-03-02 1993-09-08 池洁 一种保健牙签
US5294433A (en) * 1992-04-15 1994-03-15 The Procter & Gamble Company Use of H-2 antagonists for treatment of gingivitis
US5431927A (en) * 1992-06-16 1995-07-11 Colgate-Palmolive Company Pet food product having oral care properties
US6004587A (en) * 1992-06-25 1999-12-21 Bioxy Inc. Therapeutic, production and immunostimulatory uses of biocidal compositions
US5830511A (en) * 1992-06-25 1998-11-03 Bioxy Inc. Therapeutic, production and immunostimulatory uses of biocidal compositions
JP3333584B2 (ja) * 1993-04-19 2002-10-15 三井農林株式会社 歯質の耐酸性強化組成物
JP3464807B2 (ja) 1993-04-27 2003-11-10 サンスター株式会社 歯磨用組成物
US5451401A (en) * 1993-09-29 1995-09-19 The Procter & Gamble Company Diphosphonic acid esters as tartar control agents
CN1103776A (zh) 1993-12-17 1995-06-21 王殿安 降压防栓保健药物牙膏
GB2290233B (en) 1994-05-21 1998-06-17 Medical Express Tooth-whitening compositions containing both chlorite and chlorate salts
CN1109742A (zh) 1994-09-22 1995-10-11 许我先 心、脑血管保健牙膏
US5578293A (en) * 1994-12-06 1996-11-26 Colgate Palmolive Company Oral compositions containing stabilized stannous compounds having antiplaque and antitartar efficacy
US5639746A (en) * 1994-12-29 1997-06-17 The Procter & Gamble Company Hydroxamic acid-containing inhibitors of matrix metalloproteases
US5626838A (en) * 1995-03-13 1997-05-06 The Procter & Gamble Company Use of ketorolac for treatment of squamous cell carcinomas of the oral cavity or oropharynx
US5672598A (en) * 1995-03-21 1997-09-30 The Procter & Gamble Company Lactam-containing hydroxamic acids
TW442287B (en) * 1995-06-13 2001-06-23 American Home Produits Corp Organoleptically acceptable oral pharmaceutical composition comprising the S(+)1,8-diethyl-1-1,3,4,9-tetrahydropyrano[3,4-b] indole-1-acetic acid (Etodolac)
US6025326A (en) * 1995-07-07 2000-02-15 Intrabiotics Pharmaceuticals, Inc. Compositions and methods for the prevention and treatment of oral mucositis
AU7468096A (en) 1995-10-30 1997-05-22 Warner-Lambert Company Enhanced anti-inflammatory oral composition containing h2 receptor antagonist and antimicrobial oils
EP0803243B1 (de) * 1996-04-24 2003-03-19 Pfizer Inc. Dentalwerkstoffe enthaltend Cyclodextrine und phenolische Verbindungen
WO1997047292A1 (en) * 1996-06-12 1997-12-18 The Procter & Gamble Company Use of h2-antagonists for the manufacture of a topical composition for the treatment of colds
US5766622A (en) * 1996-08-14 1998-06-16 The Procter & Gamble Company Inhibiting undesirable taste in oral compositions
US5753217A (en) * 1996-08-14 1998-05-19 William C. Christopfel Method of reducing oral malodor
BR9712792A (pt) 1996-08-28 1999-12-14 Procter & Gamble Inibidores de metaloprotease bidentada.
HUP9903916A3 (en) * 1996-08-28 2001-06-28 Procter And Gamble Co Cincinna Phosphinic acid amides and pharmaceutical compositions containing the same
EP0923563A1 (de) 1996-08-28 1999-06-23 The Procter & Gamble Company 1,4-heterocyclische metalloproteaseinhibitoren
EP0927161B1 (de) 1996-08-28 2002-10-16 The Procter & Gamble Company Substituierte zyklische amine als metalloproteaseinhibitoren
TR199900382T2 (xx) 1996-08-28 1999-05-21 The Procter & Gamble Company Heterosiklik metaloproteaz inhibit�rleri.
BR9713186A (pt) 1996-08-28 1999-11-03 Procter & Gamble Inibidores de metaloprotease 1,3-diheterocìclicos
EP0927183B1 (de) * 1996-08-28 2004-07-28 THE PROCTER & GAMBLE COMPANY Spirocyclisch metalloprotease inhibitoren
CN1238673A (zh) 1996-10-22 1999-12-15 普罗克特和甘保尔公司 含有葡糖酸亚锡的经口组合物
EP0966278A1 (de) 1996-10-22 1999-12-29 The Procter & Gamble Company Orale zusammenstellung die zink zitratesalze enthält
NZ335780A (en) 1996-10-23 2001-01-26 Univ New York State Res Found Compositions to control oral microbial oxidation-reduction (Eh) levels and treat gingivitis-periodontitis
US5906811A (en) * 1997-06-27 1999-05-25 Thione International, Inc. Intra-oral antioxidant preparations
AU746877B2 (en) 1997-07-31 2002-05-02 Procter & Gamble Company, The Acyclic metalloprotease inhibitors
US5875799A (en) * 1997-09-23 1999-03-02 Advanced Medical Instruments, Inc. Therapeutic dental floss for treating systemic diseases
US5875798A (en) * 1997-09-23 1999-03-02 Advanced Medical Instruments, Inc. Therapeutic toothpick for treating oral and systemic diseases
CN1213534A (zh) 1997-10-06 1999-04-14 陈创 口体舒治疗保健系统牙膏
JPH11139947A (ja) 1997-11-11 1999-05-25 Sunstar Inc マトリックスメタロプロテアーゼ阻害剤含有口腔用組成物
US6228347B1 (en) * 1997-12-01 2001-05-08 Thione International, Inc. Antioxidant gel for gingival conditions
US6132702A (en) * 1998-02-27 2000-10-17 The Procter & Gamble Company Oral care compositions comprising chlorite and methods
US6350438B1 (en) * 1998-02-27 2002-02-26 The Procter & Gamble Company Oral care compositions comprising chlorite and methods
JP3763075B2 (ja) * 1998-04-24 2006-04-05 サンスター株式会社 歯周病の予防又は治療用の食品組成物、口腔用組成物及び医薬組成物
WO2007079331A2 (en) * 2005-12-13 2007-07-12 Richard Paul Bonfiglio Antibacterial oral rinse formulation for preventing coronary artery disease

Also Published As

Publication number Publication date
MXPA03000043A (es) 2003-10-15
CA2415065A1 (en) 2002-01-10
WO2002002096A2 (en) 2002-01-10
EP1294367A2 (de) 2003-03-26
US20060193790A1 (en) 2006-08-31
PE20020102A1 (es) 2002-03-06
CA2415065C (en) 2009-09-15
ES2309076T3 (es) 2008-12-16
US8277782B2 (en) 2012-10-02
JP4754155B2 (ja) 2011-08-24
WO2002002096A8 (en) 2003-11-06
EP1294367B1 (de) 2008-07-16
ATE401065T1 (de) 2008-08-15
WO2002002096A3 (en) 2002-09-12
CN1536989A (zh) 2004-10-13
JP2004501966A (ja) 2004-01-22
AU2001271544A1 (en) 2002-01-14

Similar Documents

Publication Publication Date Title
DE60134854D1 (de) Orale zubereitungen, die wirtsantwortmodulierenden wirkstoffe enthalten
DE60134855D1 (de) Orale zubereitungen, die antimikrobielle wirkstoffe enthalten zur prävention von systemischen erkrankungen
AR035482A1 (es) Uso de un compuesto de cianoquinolina para la manufactura de un medicamento para tratar o inhibir polipos colonicos
DE50211204D1 (de) Cannabis extrakten pharmazeutische zusammensetzung
AR012241A1 (es) Composicion de depuracion antimicrobiana mantenible y metodos para proporcionar efectividad residual y para tratar acne.
ATE370730T1 (de) Pharmazeutische zubereitungen, die chelatbildner/sequestriermittel enthalten und deren dermatologische verwendung
AR012172A2 (es) Composiciones farmaceuticas que comprenden analogos de lactacistina y uso de los mismos para la fabricacion de un medicamento
Greenstein Povidone‐iodine's effects and role in the management of periodontal diseases: a review
MX2007006212A (es) Medicamento oral para liberacion modificada de al menos un principio activo bajo forma multimicrocapsular.
RU2009114589A (ru) Композиции для ухода за полостью рта, содержащие комбинации антибактериальных агентов и агентов, изменяющих реакцию организма-носителя
ATE194080T1 (de) Topische zusammensetzungen, die lycd und sonstige topische aktive mittel enthalten
ATE473749T1 (de) Verwendung von rhamnolipiden zur wundheilung, behandlung und vorbeugung einer zahnfleischerkrankung und periodontaler regeneration
RS51154B (sr) Farmaceutske kompozicije koje sadrže niske koncentracije peroksida za lečenje i sprečavanje vaginalnih infekcija
AR015744A1 (es) Uso de dexmedetomidina para sedacion en terapia intensiva
ATE173930T1 (de) Pharmazeutische zusammensetzungen zur topischen anwendung die ein chelatierungsmittel, ein tocopherol und einen antimikrobiellen wirkstoff enthalten
GEP20043231B (en) Resorcinol Composition
DE60020556D1 (de) Ionenkanal modulierende mittel
KR20040087380A (ko) 구강세균에 대한 항균효과가 우수한 에센셜 오일 조성물
Shetty et al. Highlights on role of antibiotics in periodontics
Solomon et al. THE LOCAL ANTIBIOTHERAPY IN THE PERIODONTAL DISEASE TREATMENT. REVIEW.
CN1069516C (zh) 一种槟榔药物牙膏组合物
ECSP034647A (es) Uso de factor vii actividad de coagulacion para tratar sangrados graves inducidos por terapia
DOP2001000259A (es) Sistema de surfactantes para aumentar la captación de agente antibacteriano al tejido dental
YU75002A (sh) Lokalna antioksidantna vitaminska smeša za negu kože
Karthikeyan et al. Non-Antibacterial Implications of Tetracyclines in the Management of Periodontitis: An Update. J Immunodefic Disor 2: 1

Legal Events

Date Code Title Description
8363 Opposition against the patent